Ken Fisher's position in Boston Scientific is currently worth $20.4M. That's 0.01% of their equity portfolio (327th largest holding). The first Boston Scientific trade was made in Q4 2018. Since then Ken Fisher bought shares 27 more times and sold shares on two occasions. The investor's estimated purchase price is $31.9M, resulting in a loss of 36%.
Key Players: Leading players profiled in the Medical Supplies Market report include Thermo Fisher Scientific Inc. (US), Halyard Health, Inc. (US), Baxter Int...
Wireless Brain Implant is a device that could provide deep insight into the mechanisms of pain, depression, addiction, and certain diseases by observing the ...